Search results

Articles (5)

Journals (0)

1-5 of 5 results for Ropeginterferon alfa-2b

Sort by:

Relevance

Select all

Sort by:

Relevance

Open accessBrief reportFirst published 2026

Neutrophil-to-lymphocyte ratio half reduction as a surrogate of molecular response in polycythemia vera treated with ropeginterferon alfa-2b

Seug Yun Yoon, Sung-Soo Yoon, Deok-Hwan Yang [...]

Therapeutic Advances in Hematology

Open accessCase reportFirst published 2026

A Hidden Driver Mutation in Myeloproliferative Neoplasms: SH2B3 and Diagnostic Implications and Response to Ropeginterferon Alfa-2b

Karina Basmajian, Lauren Rachel Chang Borecky, Mojtaba Akhtari

Journal of Investigative Medicine High Impact Case Reports

Open accessReview articleFirst published 2024

Interferons in the treatment of myeloproliferative neoplasms

Pankit Vachhani, John Mascarenhas, Prithviraj Bose [...]

Therapeutic Advances in Hematology

Open accessReview articleFirst published 2019

Updates in the management of polycythemia vera and essential thrombocythemia

Prithviraj Bose, Srdan Verstovsek

Therapeutic Advances in Hematology

Open accessCase reportFirst published 2025

Management of common autoimmune diseases in patients with myeloproliferative neoplasms treated with pegylated interferon alfa—case report,review of the literature and multidisciplinary clinical practice recommendations

Axel Rüfer, Christoph Brand, Andrea de Gottardi [...]

Therapeutic Advances in Hematology

Search results

Articles (5)

Journals (0)

1-5 of 5 results for Ropeginterferon alfa-2b

Sort by:

Relevance

Select all

Sort by:

Relevance

Open accessBrief reportFirst published 2026

Neutrophil-to-lymphocyte ratio half reduction as a surrogate of molecular response in polycythemia vera treated with ropeginterferon alfa-2b

Seug Yun Yoon, Sung-Soo Yoon, Deok-Hwan Yang [...]

Therapeutic Advances in Hematology

Open accessCase reportFirst published 2026

A Hidden Driver Mutation in Myeloproliferative Neoplasms: SH2B3 and Diagnostic Implications and Response to Ropeginterferon Alfa-2b

Karina Basmajian, Lauren Rachel Chang Borecky, Mojtaba Akhtari

Journal of Investigative Medicine High Impact Case Reports

Open accessReview articleFirst published 2024

Interferons in the treatment of myeloproliferative neoplasms

Pankit Vachhani, John Mascarenhas, Prithviraj Bose [...]

Therapeutic Advances in Hematology

Open accessReview articleFirst published 2019

Updates in the management of polycythemia vera and essential thrombocythemia

Prithviraj Bose, Srdan Verstovsek

Therapeutic Advances in Hematology

Open accessCase reportFirst published 2025

Management of common autoimmune diseases in patients with myeloproliferative neoplasms treated with pegylated interferon alfa—case report,review of the literature and multidisciplinary clinical practice recommendations

Axel Rüfer, Christoph Brand, Andrea de Gottardi [...]

Therapeutic Advances in Hematology